KBIA talked to Dr. Rebecca Hamel about the risks expecting mothers face with COVID-19 and why all women who are pregnant or hoping to become pregnant should get the vaccine as soon as possible.
KSHB talked to Dr. Rebecca Hamel about why pregnant mothers should get vaccinated as soon as possible with increased risks due to the emergence of the delta variant.
Dapagliflozin improved symptoms and physical limitations in patients with heart failure (HF) with preserved ejection fraction, according to results from the PRESERVED-HF trial.
Dapagliflozin eases symptoms and physical limitations among patients who have heart failure with preserved ejection fraction (HFpEF) within a relatively short time period.
Treatment with dapagliflozin improves the symptoms of patients with heart failure with preserved ejection fraction (HFpEF), according to new findings presented at the Heart Failure Society of America's Annual Scientific Meeting.
The SGLT2 inhibitor dapagliflozin scored a clear win in a randomized, controlled trial with more than 300 U.S. patients with heart failure with preserved ejection fraction (HFpEF).